Functional Health Fiber One.bio's plant-based fibers restore gut signaling to support metabolic and immune health in foods without compromising taste or texture, creating a compelling value proposition for food and beverage brands seeking functional, label-friendly ingredients.

Funding Momentum A Dec 2024 Series A of $27M and a Jan 2026 launch of clinically validated fiber signal strong growth traction and capacity to add pilot programs, co-development deals, and strategic partnerships with mid-market to large F&B players.

F&B Partnership Focus The business model centers on integrating fiber directly into processed foods and beverages, offering opportunities for ingredient sourcing, R&D collaboration, and private-label or co-branded products with food and beverage manufacturers.

Clinical Validation Edge Clinically validated claims around metabolic and immune health can accelerate regulatory clearance, marketing claims, and speed to market, making One.bio an attractive partner for CPGs seeking credible health benefits.

Expansion Potential With a small team and growing US revenue, there are opportunities to scale domestically first and then expand internationally through partnerships with contract manufacturers, distributors, and other ecosystem players seeking novel plant-based fiber solutions.